<DOC>
	<DOCNO>NCT00436267</DOCNO>
	<brief_summary>RATIONALE : Specialized radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue . Drugs use chemotherapy , fluorouracil , work different way stop growth tumor cell , either kill cell stop divide . Giving radiation therapy different way give together chemotherapy may kill tumor cell . PURPOSE : This phase II trial study side effect well give internal radiation therapy external radiation therapy together fluorouracil work treat patient newly diagnose recurrent pancreatic cancer liver metastases remove surgery .</brief_summary>
	<brief_title>Internal Radiation Therapy With Y-90 Microspheres , External Radiation Therapy With Tomotherapy , Fluorouracil Treating Patients With Newly Diagnosed Recurrent Pancreatic Cancer Liver Metastases That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine tumor response patient unresectable , newly diagnose recurrent pancreatic cancer liver metastasis treat selective internal radiotherapy yttrium Y 90 microspheres , selective external radiotherapy tomotherapy , fluoroucacil . - Determine hepatic systemic toxicity regimen patient . Secondary - Determine efficacy regimen , term time progression survival , patient . OUTLINE : Patients receive fluorouracil IV continuously day 1-4 . Patients undergo selective internal radiotherapy yttrium Y 90 microspheres day 2 selective external radiotherapy tomotherapy day 3 . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm pancreatic cancer liver metastases Unresectable disease AND meet follow criterion : Newly diagnose disease No prior treatment Received prior treatment progress Underwent prior pancreatectomy progress Liveronly disease ( receive selective internal radiotherapy ) No know CNS metastases No know diffuse peritoneal metastases PATIENT CHARACTERISTICS : Karnofsky performance status 80100 % Life expectancy &gt; 3 month WBC ≥ 1,500/mm³ Platelet count ≥ 100,000/mm³ Hemoglobin ≥ 9 g/dL Bilirubin &lt; 2 mg/dL ( without extrahepatic biliary obstruction ) Albumin &gt; 2 g/dL Creatinine &lt; 2 mg/dL Not pregnant PRIOR CONCURRENT THERAPY : See Disease Characteristics Prior surgery , chemotherapy , biologic therapy allow No prior external beam radiotherapy liver pancreatic bed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>liver metastasis</keyword>
</DOC>